Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling

Journal of Experimental Medicine

Volumn 205, Issue 6, 2008, Pages 1491-1503

  Cao, Wangsen ^a   Bao, Clare ^a   Padalko, Elizaveta ^a   Lowenstein, Charles J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; LIPOPOLYSACCHARIDE; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PROTEIN P300; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT MOUSE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; WILD TYPE;

ACETYLATION; ANIMALS; BLOTTING, NORTHERN; BUTYRATES; CELL LINE; DUAL SPECIFICITY PHOSPHATASE 1; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; IMMUNITY, NATURAL; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 45149132474     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20071728     Document Type: Article

References (73)

1. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-145.
2. Gordon, S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell. 111:927-930.
3. Barton, G.M., and R. Medzhitov. 2003. Toll-like receptor signaling pathways. Science. 300:1524-1525.
4. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
5. Dong, C., R.J. Davis, and R.A. Flavell. 2001. Signaling by the JNK group of MAP kinases. c-jun N-terminal kinase. J. Clin. Immunol. 21:253-257.
6. Dong, C., R.J. Davis, and R.A. Flavell. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20:55-72.
7. Han, J., and R.J. Ulevitch. 1999. Emerging targets for anti-inflammatory therapy. Nat. Cell Biol. 1:E39-E40.
8. Davis, R.J. 2000. Signal transduction by the JNK group of MAP kinases. Cell. 103:239-252.
9. Chang, L., and M. Karin. 2001. Mammalian MAP kinase signalling cascades. Nature. 410:37-40.
10. Morrison, D.K., and R.J. Davis. 2003. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19:91-118.
11. Whitmarsh, A.J., and R.J. Davis. 1999. Signal transduction by MAP kinases: regulation by phosphorylation-dependent switches. Sci. STKE. 1999:PE1.
12. Lu, H.T., D.D. Yang, M. Wysk, E. Gatti, I. Mellman, R.J. Davis, and R.A. Flavell. 1999. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 18:1845-1857.
13. Blander, J.M., and R. Medzhitov. 2004. Regulation of phagosome maturation by signals from toll-like receptors. Science. 304:1014-1018.
14. Doyle, S.E., R.M. O'Connell, G.A. Miranda, S.A. Vaidya, E.K. Chow, P.T. Liu, S. Suzuki, N. Suzuki, R.L. Modlin, W.C. Yeh, et al. 2004. Toll-like receptors induce a phagocytic gene program through p38. J. Exp. Med. 199:81-90.
15. Liew, F.Y., D. Xu, E.K. Brint, and L.A. O'Neill. 2005. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5:446-458.
16. Wells, C.A., T. Ravasi, and D.A. Hume. 2005. Inflammation suppressor genes: please switch out all the lights. J. Leukoc. Biol. 78:9-13.
17. Kobayashi, K.S., and R.A. Flavell. 2004. Shielding the double-edged sword: negative regulation of the innate immune system. J. Leukoc. Biol. 75:428-433.
18. Burns, K., J. Clatworthy, L. Martin, F. Martinon, C. Plumpton, B. Maschera, A. Lewis, K. Ray, J. Tschopp, and F. Volpe. 2000. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2:346-351.
19. Kinjyo, I., T. Hanada, K. Inagaki-Ohara, H. Mori, D. Aki, M. Ohishi, H. Yoshida, M. Kubo, and A. Yoshimura. 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity. 17:583-591.
20. Nakagawa, R., T. Naka, H. Tsutsui, M. Fujimoto, A. Kimura, T. Abe, E. Seki, S. Sato, O. Takeuchi, K. Takeda, et al. 2002. SOCS-1 participates in negative regulation of LPS responses. Immunity. 17:677-687.
21. Sly, L.M., M.J. Rauh, J. Kalesnikoff, C.H. Song, and G. Krystal. 2004. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity. 21:227-239.
22. Wald, D., J. Qin, Z. Zhao, Y. Qian, M. Naramura, L. Tian, J. Towne, J.E. Sims, G.R. Stark, and X. Li. 2003. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4:920-927.
23. Garlanda, C., F. Riva, N. Polentarutti, C. Buracchi, M. Sironi, M. De Bortoli, M. Muzio, R. Bergottini, E. Scanziani, A. Vecchi, et al. 2004. Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc. Natl. Acad. Sci. USA. 101:3522-3526.
24. Diehl, G.E., H.H. Yue, K. Hsieh, A.A. Kuang, M. Ho, L.A. Morici, L.L. Lenz, D. Cado, L.W. Riley, and A. Winoto. 2004. TRAIL-R as a negative regulator of innate immune cell responses. Immunity. 21:877-889.
25. Zhang, Y., J.N. Blattman, N.J. Kennedy, J. Duong, T. Nguyen, Y. Wang, R.J. Davis, P.D. Greenberg, R.A. Flavell, and C. Dong. 2004. Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5. Nature. 430:793-797.
26. Shepherd, E.G., Q. Zhao, S.E. Welty, T.N. Hansen, C.V. Smith, and Y. Liu. 2004. The function of mitogen-activated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages. J. Biol. Chem. 279:54023-54031.
27. Zhao, Q., E.G. Shepherd, M.E. Manson, L.D. Nelin, A. Sorokin, and Y. Liu. 2005. The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J. Biol. Chem. 280:8101-8109.
28. Chi, H., S.P. Barry, R.J. Roth, J.J. Wu, E.A. Jones, A.M. Bennett, and R.A. Flavell. 2006. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. USA. 103:2274-2279.
29. Keyse, S.M. 2000. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12:186-192.
30. Camps, M., A. Nichols, and S. Arkinstall. 2000. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J. 14:6-16.
31. Theodosiou, A., and A. Ashworth. 2002. MAP kinase phosphatases. Genome Biol. 3:S3009.
32. Keyse, S.M. 1998. Protein phosphatases and the regulation of MAP kinase activity. Semin. Cell Dev. Biol. 9:143-152.
33. Tonks, N.K. 2005. Redox redux: revisiting PTPs and the control of cell signaling. Cell. 121:667-670.
34. Tonks, N.K., and B.G. Neel. 2001. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr. Opin. Cell Biol. 13:182-195.
35. Slack, D.N., O.M. Seternes, M. Gabrielsen, and S.M. Keyse. 2001. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1. J. Biol. Chem. 276:16491-16500.
36. Dowd, S., A.A. Sneddon, and S.M. Keyse. 1998. Isolation of the human genes encoding the pyst1 and Pyst2 phosphatases: characterisation of Pyst2 as a cytosolic dual-specificity MAP kinase phosphatase and its catalytic activation by both MAP and SAP kinases. J. Cell Sci. 111 (Pt 22): 3389-3399.
37. Tanoue, T., T. Moriguchi, and E. Nishida. 1999. Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5. J. Biol. Chem. 274:19949-19956.
38. Camps, M., A. Nichols, C. Gillieron, B. Antonsson, M. Muda, C. Chabert, U. Boschert, and S. Arkinstall. 1998. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science. 280:1262-1265.
39. Brondello, J.M., J. Pouyssegur, and F.R. McKenzie. 1999. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science. 286:2514-2517.
40. Hammer, M., J. Mages, H. Dietrich, A. Servatius, N. Howells, A.C. Cato, and R. Lang. 2006. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J. Exp. Med. 203:15-20.
41. Zhao, Q., X. Wang, L.D. Nelin, Y. Yao, R. Matta, M.E. Manson, R.S. Baliga, X. Meng, C.V. Smith, J.A. Bauer, et al. 2006. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203:131-140.
42. Salojin, K.V., I.B. Owusu, K.A. Millerchip, M. Potter, K.A. Platt, and T. Oravecz. 2006. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J. Immunol. 176:1899-1907.
43. Peterson, C.L. 2002. HDAC's at work: everyone doing their part. Mol. Cell. 9:921-922.
44. Minucci, S., and P.G. Pelicci. 2006. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer. 6:38-51.
45. Yang, X.J., and E. Seto. 2007. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene. 26:5310-5318.
46. Chen, L.f., W. Fischle, E. Verdin, and W.C. Greene. 2001. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science. 293:1653-1657.
47. Yuan, Z.L., Y.J. Guan, D. Chatterjee, and Y.E. Chin. 2005. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science. 307:269-273.
48. Gu, W., and R.G. Roeder. 1997. Activation of p53 sequence-specifi c DNA binding by acetylation of the p53 C-terminal domain. Cell. 90:595-606.
49. Koyama, Y., M. Adachi, M. Sekiya, M. Takekawa, and K. Imai. 2000. Histone deacetylase inhibitors suppress IL-2-mediated gene expression prior to induction of apoptosis. Blood. 96:1490-1495.
50. Leoni, F., A. Zaliani, G. Bertolini, G. Porro, P. Pagani, P. Pozzi, G. Dona, G. Fossati, S. Sozzani, T. Azam, et al. 2002. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc. Natl. Acad. Sci. USA. 99:2995-3000.
51. Mishra, N., C.M. Reilly, D.R. Brown, P. Ruiz, and G.S. Gilkeson. 2003. Histone deacetylase inhibitors modulate renal disease in the MRLlpr/lpr mouse. J. Clin. Invest. 111:539-552.
52. Chung, Y.L., M.Y. Lee, A.J. Wang, and L.F. Yao. 2003. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. Mol. Ther. 8:707-717.
53. Reilly, C.M., N. Mishra, J.M. Miller, D. Joshi, P. Ruiz, V.M. Richon, P.A. Marks, and G.S. Gilkeson. 2004. Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid. J. Immunol. 173:4171-4178.
54. Reddy, P., Y. Maeda, K. Hotary, C. Liu, L.L. Reznikov, C.A. Dinarello, and J.L. Ferrara. 2004. Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus- leukemia effect. Proc. Natl. Acad. Sci. USA. 101:3921-3926.
55. Choi, J.H., S.W. Oh, M.S. Kang, H.J. Kwon, G.T. Oh, and D.Y. Kim. 2005. Trichostatin A attenuates airway inflammation in mouse asthma model. Clin. Exp. Allergy. 35:89-96.
56. Bode, K.A., K. Schroder, D.A. Hume, T. Ravasi, K. Heeg, M.J. Sweet, and A.H. Dalpke. 2007. Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment. Immunology. 122:596-606.
57. Aung, H.T., K. Schroder, S.R. Himes, K. Brion, W. van Zuylen, A. Trieu, H. Suzuki, Y. Hayashizaki, D.A. Hume, M.J. Sweet, and T. Ravasi. 2006. LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression. FASEB J. 20:1315-1327.
58. Singh, K., J.L. Balligand, T.A. Fischer, T.W. Smith, and R.A. Kelly. 1996. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha. J. Biol. Chem. 271:1111-1117.
59. Zarubin, T., and J. Han. 2005. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15:11-18.
60. Ge, B., H. Gram, F. Di Padova, B. Huang, L. New, R.J. Ulevitch, Y. Luo, and J. Han. 2002. MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science. 295:1291-1294.
61. Huang, W., S. Zhao, S. Ammanamanchi, M. Brattain, K. Venkatasubbarao, and J.W. Freeman. 2005. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. J. Biol. Chem. 280:10047-10054.
62. Munshi, N., M. Merika, J. Yie, K. Senger, G. Chen, and D. Thanos. 1998. Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol. Cell. 2:457-467.
63. Bereshchenko, O.R., W. Gu, and R. Dalla-Favera. 2002. Acetylation inactivates the transcriptional repressor BCL6. Nat. Genet. 32:606-613.
64. Boyes, J., P. Byfield, Y. Nakatani, and V. Ogryzko. 1998. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature. 396:594-598.
65. Zhang, W., and J.J. Bieker. 1998. Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proc. Natl. Acad. Sci. USA. 95:9855-9860.
66. Martinez-Balbas, M.A., U.M. Bauer, S.J. Nielsen, A. Brehm, and T. Kouzarides. 2000. Regulation of E2F1 activity by acetylation. EMBO J. 19:662-671.
67. Tanoue, T., T. Yamamoto, and E. Nishida. 2002. Modular structure of a docking surface on MAPK phosphatases. J. Biol. Chem. 277:22942-22949.
68. Mujtaba, S., Y. He, L. Zeng, A. Farooq, J.E. Carlson, M. Ott, E. Verdin, and M.M. Zhou. 2002. Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol. Cell. 9:575-586.
69. Mandl, M., D.N. Slack, and S.M. Keyse. 2005. Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5. Mol. Cell. Biol. 25:1830-1845.
70. Chen, P., D. Hutter, X. Yang, M. Gorospe, R.J. Davis, and Y. Liu. 2001. Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically. J. Biol. Chem. 276:29440-29449.
71. Kamata, H., S. Honda, S. Maeda, L. Chang, H. Hirata, and M. Karin. 2005. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell. 120:649-661.
72. Morgenstern, J.P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
73. Cao, W., C. Bao, and C.J. Lowenstein. 2003. Inducible nitric oxide synthase expression inhibition by adenovirus E1A. Proc. Natl. Acad. Sci. USA. 100:7773-7778.